EDIT
Price
$2.18
Change
-$0.23 (-9.54%)
Updated
Dec 1, 04:59 PM (EDT)
Capitalization
235.26M
80 days until earnings call
Intraday BUY SELL Signals
KYMR
Price
$67.12
Change
-$0.76 (-1.12%)
Updated
Dec 1, 04:31 PM (EDT)
Capitalization
4.88B
80 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

EDIT vs KYMR

Header iconEDIT vs KYMR Comparison
Open Charts EDIT vs KYMRBanner chart's image
Editas Medicine
Price$2.18
Change-$0.23 (-9.54%)
Volume$20.6K
Capitalization235.26M
Kymera Therapeutics
Price$67.12
Change-$0.76 (-1.12%)
Volume$1.68K
Capitalization4.88B
EDIT vs KYMR Comparison Chart in %
EDIT
Daily Signal:
Gain/Loss:
KYMR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
EDIT vs. KYMR commentary
Dec 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDIT is a Hold and KYMR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 01, 2025
Stock price -- (EDIT: $2.41 vs. KYMR: $67.88)
Brand notoriety: EDIT and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDIT: 38% vs. KYMR: 62%
Market capitalization -- EDIT: $235.26M vs. KYMR: $4.88B
EDIT [@Biotechnology] is valued at $235.26M. KYMR’s [@Biotechnology] market capitalization is $4.88B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDIT’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • EDIT’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, KYMR is a better buy in the long-term than EDIT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDIT’s TA Score shows that 5 TA indicator(s) are bullish while KYMR’s TA Score has 4 bullish TA indicator(s).

  • EDIT’s TA Score: 5 bullish, 5 bearish.
  • KYMR’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than EDIT.

Price Growth

EDIT (@Biotechnology) experienced а -0.41% price change this week, while KYMR (@Biotechnology) price change was +2.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.89%. For the same industry, the average monthly price growth was -0.60%, and the average quarterly price growth was +59.52%.

Reported Earning Dates

EDIT is expected to report earnings on Feb 19, 2026.

KYMR is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (+3.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($4.88B) has a higher market cap than EDIT($235M). EDIT YTD gains are higher at: 89.764 vs. KYMR (68.730). EDIT has higher annual earnings (EBITDA): -227.72M vs. KYMR (-267.03M). KYMR has more cash in the bank: 665M vs. EDIT (179M). EDIT has less debt than KYMR: EDIT (21.1M) vs KYMR (85.7M). KYMR has higher revenues than EDIT: KYMR (44.7M) vs EDIT (38.9M).
EDITKYMREDIT / KYMR
Capitalization235M4.88B5%
EBITDA-227.72M-267.03M85%
Gain YTD89.76468.730131%
P/E RatioN/AN/A-
Revenue38.9M44.7M87%
Total Cash179M665M27%
Total Debt21.1M85.7M25%
FUNDAMENTALS RATINGS
EDIT: Fundamental Ratings
EDIT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EDITKYMR
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
84%
Momentum
ODDS (%)
Bearish Trend 6 days ago
82%
Bullish Trend 4 days ago
79%
MACD
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 11 days ago
89%
N/A
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
88%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
EDIT
Daily Signal:
Gain/Loss:
KYMR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EBKOF110.342.77
+2.58%
Erste Group Bank AG
DPMLF27.870.60
+2.19%
DPM Metals Inc.
SLDX0.03N/A
N/A
STELLA DIAGNOSTICS INC.
OSGCF13.66N/A
N/A
Osg Corp. Co. Ltd.
QUCT2030.00N/A
N/A
Queen City Investments, Inc.

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with NRIX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+0.03%
NRIX - KYMR
64%
Loosely correlated
+2.79%
VERA - KYMR
60%
Loosely correlated
+1.26%
KURA - KYMR
56%
Loosely correlated
+1.25%
RGNX - KYMR
54%
Loosely correlated
+0.98%
IDYA - KYMR
53%
Loosely correlated
-0.72%
More